Modifications of the 4,4′-residues and SAR studies of biphalin, a highly potent opioid receptor active peptide

被引:25
作者
Li, GG
Haq, W
Xiang, L
Lou, BS
Hughes, R
De Leon, IA
Davis, P
Gillespie, TJ
Romanowski, M
Zhu, XY
Misicka, A
Lipkowski, AW
Porreca, F
Davis, TP
Yamamura, HI
O'Brien, DF
Hruby, VJ [1 ]
机构
[1] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA
[2] Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA
关键词
D O I
10.1016/S0960-894X(98)00065-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Modifications of 4,4' residues of Biphalin have resulted in greater binding selectivity and biological potency for the mu opioid receptor. A higher partition coefficient across the phospholipid bilayer membrane has been achieved by using a beta-branched unusual amino acids. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:555 / 560
页数:6
相关论文
共 26 条
[1]  
COSTA T, 1981, PEPTIDES SYNTHESIS S, P625
[2]   NARCOTIC ANTAGONISTIC POTENCY OF BIVALENT LIGANDS WHICH CONTAIN BETA-NALTREXAMINE - EVIDENCE FOR BRIDGING BETWEEN PROXIMAL RECOGNITION SITES [J].
EREZ, M ;
TAKEMORI, AE ;
PORTOGHESE, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (07) :847-849
[3]  
FARLIE DP, 1995, CURR MED CHEM, V2, P654
[4]  
HORAN PJ, 1993, J PHARMACOL EXP THER, V265, P1446
[5]   STRATEGIES IN THE DEVELOPMENT OF PEPTIDE ANTAGONISTS [J].
HRUBY, VJ .
PROGRESS IN BRAIN RESEARCH, 1992, 92 :215-224
[7]   RECENT DEVELOPMENTS IN THE DESIGN OF RECEPTOR SPECIFIC OPIOID-PEPTIDES [J].
HRUBY, VJ ;
GEHRIG, CA .
MEDICINAL RESEARCH REVIEWS, 1989, 9 (03) :343-401
[8]   CONFORMATIONAL AND TOPOGRAPHICAL CONSIDERATIONS IN THE DESIGN OF BIOLOGICALLY-ACTIVE PEPTIDES [J].
HRUBY, VJ .
BIOPOLYMERS, 1993, 33 (07) :1073-1082
[9]   EMERGING APPROACHES IN THE MOLECULAR DESIGN OF RECEPTOR-SELECTIVE PEPTIDE LIGANDS - CONFORMATIONAL, TOPOGRAPHICAL AND DYNAMIC CONSIDERATIONS [J].
HRUBY, VJ ;
ALOBEIDI, F ;
KAZMIERSKI, W .
BIOCHEMICAL JOURNAL, 1990, 268 (02) :249-262
[10]  
HRUBY VJ, 1994, PEPTIDES CHEM STRUCT, P3